An increase in the number of investigators who possess the research knowledge and training from the bench to the bedside is essential to the Wisconsin Head & Neck SPORE overarching goal to advance translational research impacting this increasingly common disease. This Career Enhancement Program (CEP) provides an outstanding structure and mechanism to cultivate the development of solid research careers for junior faculty and mid-level investigators desiring to focus their careers towards translational research in Head and Neck Cancer (HNC).
The specific aim of the CEP is to provide scientists with essential training and career enhancement support such that they develop into successful, independently funded translational researchers and leaders in the field of HNC. Our goal is to produce future scientists, including physician scientists, who will meet the great need for innovation in methods to prevent and treat these devastating malignancies. The CEP will support up to four awardees at any given time. Awardees will receive $50,000 per year for up to two years to support their research career enhancement activities. The program boasts strong leadership, a wealth of expertise and resources, an individualized clinical and scientific curriculum, a strong pool of exceptional mentors and potential applicants, and well-defined processes for recruitment and assessment. The program will foster the development of knowledge, skills, professional attitudes, and experience required for successful academic careers in HNC translational research.
Advancing research discoveries into improved care for patients with HNC requires expansion of the pool of scientists with translational research knowledge. This program will provide formal career enhancement training for future scientists desiring to develop novel prevention and treatment strategies for head and neck cancer.
| McDaniel, Nellie K; Cummings, Christopher T; Iida, Mari et al. (2018) MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents. Mol Cancer Ther 17:2297-2308 |
| Blitzer, Grace C; Rosenberg, Stephen A; Anderson, Bethany M et al. (2018) Results From 10 Years of a Free Oral Cancer Screening Clinic at a Major Academic Health Center. Int J Radiat Oncol Biol Phys 102:146-148 |
| Burr, Adam R; Harari, Paul M; Ko, Huaising C et al. (2018) HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients. Otorhinolaryngol Head Neck Surg 3: |
| Elsaid, Mohamed Y; Shahi, Ankita; Wang, Albert R et al. (2018) Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog. Mol Cancer Ther 17:2320-2328 |
| Jeong, Woo-Jin; Bu, Jiyoon; Kubiatowicz, Luke J et al. (2018) Peptide-nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms? Nano Converg 5:38 |
| Nyman, Patrick E; Buehler, Darya; Lambert, Paul F (2018) Loss of Function of Canonical Notch Signaling Drives Head and Neck Carcinogenesis. Clin Cancer Res 24:6308-6318 |
| Ko, Huaising C; Chen, Shuai; Wieland, Aaron M et al. (2017) Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database. Head Neck 39:2159-2170 |
| Werner, Lauryn R; Kler, Jasdeep S; Gressett, Monica M et al. (2017) Transcriptional-mediated effects of radiation on the expression of immune susceptibility markers in melanoma. Radiother Oncol 124:418-426 |
| Prabakaran, Prashanth J; Javaid, Amal M; Swick, Adam D et al. (2017) Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition. Clin Cancer Res 23:6044-6053 |
| Ko, Huaising C; Harari, Paul M; Chen, Shuai et al. (2017) Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx. JAMA Otolaryngol Head Neck Surg 143:1126-1133 |
Showing the most recent 10 out of 12 publications
